Cellis will be present at the upcoming AACR Annual Meeting, taking place April 25–30 in Chicago, where leaders in oncology research gather to shape the future of cancer treatment. We’re proud to contribute to this global conversation with new developments in macrophage-based therapies.
We invite you to visit our three poster presentations:
PO.ET02.08
Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors
April 28, 9:00 AM – 12:00 PM | Section 23
PO.CL06.01
Macrophage-ferritin-drug conjugates: a novel approach to overcome glioblastoma drug resistance and induce long-term tumor immunity
April 28, 2:00 PM – 5:00 PM | Section 27
PO.IM01.16
Macrophage-based immunotherapy of platinum-resistant ovarian cancer
April 29, 2:00 PM – 5:00 PM | Section 40
We look forward to insightful discussions and potential collaborations in Chicago.
#AACR2025 #MacrophageTherapy #ImmunoOncology #CellTherapy
